top of page

May 4-5, 2022 MIT Webconference

The Longwood Healthcare Leaders Spring meeting is centered on MIT’s Koch Institute via webconference with leading biopharma CEOs, heads of R&D, top academic researchers, and healthcare investors, co-hosted by Nobel laureate and Biogen/Alnylam co-founder Phil Sharp.

Featured Speakers

Spaekers
Agenda

These meetings are focused on accelerating the translation of discoveries into medicines to help patients; substantial donations enabled by these meetings benefit Life Science Cares, The Boston Foundation, BSO, Harvard Medical School, MIT, and other charities.

LONGWOOD HEALTHCARE LEADERS SPRING WEBCONFERENCE

AGENDA | MAY 4-5, 2022

Newco to Established: Bulding a Biotech
BIG BIOPHARMA R&D 
8:30 Wed FIRESIDE CHAT
SPOTLIGHT ON MIT INNOVATION
HOW M&A SPURS INNOVATION
EXPEDITING RESEARCH FOR TREATMENTS AND CURES
10:20Wed FIRESIDE CHAT
PLACING PATIENTS AT THE CENTER
MAINTAINING CROSS-INDUSTRY COLLABORATION
CREATING A WORLD WITHOUT DISEASE
ACCELERATING DRUG DEVELOPMENT
ADVANCING PLATFORM TECHNOLOGIES
1:30 WED FIRESIDE CHAT
CLINICAL TRIAL EFFICIENCY
DESIGNING THE DEAL
DRUG DISCOVERY SCIENCES
CULTIVATING AN ECOSYSTEM OF PARTNERS
MAKING SMART INVESTMENTS

WEDNESDAY, MAY 4, 2022

10:40 am

PLACING PATIENTS AT THE CENTER

Michael Ackermann, Chair, Tarsus

Stewart Campbell, CEO, Axial Therapeutics

Mary Fisher, CEO, Colorescience

Joanne Waldstreicher, CMO, Johnson & Johnson

Moderator: Al Beardsley, COO, Galera Therapeutics

11:15 am

MAINTAINING CROSS-INDUSTRY COLLABORATION

Angus Grant, CBO, BeiGene

Aamir Malik, Chief Business Innovation Officer, Pfizer

Rachel Mears, Partner, Jeito Capital

Amit Mehta, Head, Partnering, gRED, Genentech

Amanda Wagner, CEO, Immunitas

Moderator: Gaurica Chacko, Global Domain Leader, Life Sciences, Wipro

1:00 pm

ADVANCING PLATFORM TECHNOLOGIES

Manuel Aivado, CEO, Aileron Therapeutics

Pablo Cagnoni, CEO, Rubius Therapeutics

Simon Harnest, CIO, Metagenomi

Phil Johnson, CEO, Interius Bio

David Southwell, CEO, TScan Therapeutics

Moderator: Michal Preminger, Head, Innovation, Johnson & Johnson, East North America

1:50 pm

CLINICAL TRIAL EFFICIENCY

Christian Antoni, Chief Development Officer, EQRx

Aoife Brennan, CEO, Synlogic

Marc Lipsitch, Director, Center for Communicable Disease Dynamics, Harvard

James Sapirstein, CEO, First Wave Therapeutics

Moderator: Alise Reicin, CEO, Tectonic Therapeutics

9:20 am

HOW M&A SPURS INNOVATION

Liz Leveille, Head, BD&L Boston & European Innovation Hubs, Merck

Ivana Magovcevic-Liebisch, CEO, Vigil Neuroscience

Greg Mayes, CEO, Antios Therapeutics

Matthias Müllenbeck, Head, Global BD & Alliance Management, Merck KGaA

Moderator: Chad Shear, Principal, Fish & Richardson

8:50 am

SPOTLIGHT ON MIT INNOVATION

Regina Barzilay, Distinguished Professor for AI & Health, School of Engineering, MIT

Kipp Weiskopf, Valhalla Fellow, Whitehead Institute for Biomedical Research

Jonathan Weissman, Professor, Biology, MIT

Moderator: Jane Wilkinson, Executive Director, Koch Institute, MIT

8:30 am

REGULATORY KEYNOTE

Peter Marks, Director, Center for Biologics Evaluation and Research, FDA

Andy Plump, President, R&D, Takeda

Moderator: Christoph Westphal, General Partner, Longwood Fund 

9:50 am

EXPEDITING RESEARCH FOR TREATMENTS AND CURES

Chun-Lin Chen, CEO, Medicilon

Raj Devraj, CEO, Rectify Pharmaceuticals

Bill Hinshaw, CEO, Axcella Therapeutics

Peter Lebowitz, Global Oncology Therapeutic Area Head, Janssen

Reenie McCarthy, CEO, Stealth BioTherapeutics

Moderator: Chen Schor, CEO, Adicet Bio

2:50 pm

DRUG DISCOVERY SCIENCES

Annalisa D’Andrea, President & Chief Scientific Officer, ImmuneID

Marion Dorsch, President & CSO, Atavistik Bio

Larry Hamann, CEO, Interdict Bio

Cigall Kadoch, Associate Professor, Dana-Farber Cancer Institute

Saul Kato, CEO, Herophilus

Moderator: Art Krieg, CSO, Checkmate Pharmaceuticals

3:40 pm 

CULTIVATING AN ECOSYSTEM OF PARTNERS

Percival Barretto-KoCEO, Plexium

Marianne De Backer, EVP, Head, Global BD&L, Bayer

Aakanksha Khandelwal, Global Commercial Lead, Oncology, Daiichi Sankyo

Chris Viehbacher, Founding Partner, Gurnet Point Capital

Henry Walke, Director of the Center for Preparedness and Response, CDC

Moderator: Ari Schaefer, Co-President, Klick Health

4:10 pm

MAKING SMART INVESTMENTS

Lori Hu, Managing Director, Vertex Ventures HC

Matthias Kleinz, SVP, Translational Sciences, UPMC Enterprises

Kyle Lefkoff, General Partner, Boulder Ventures

Judith Li, Partner, Lilly Asia Ventures

Marie-Claire Peakman, Principal, Pfizer Ventures

Moderator: Aleks Radovic-Moreno, Partner, Longwood Fund

2:20 pm

DESIGNING THE DEAL

Robert Blum, CEO, Cytokinetics

Jennifer Cayer, CBO, Pulmocide

Travis Engelman, Head, BD, Cytiva

Philippe Lopes-Fernandes, CBO, Ipsen

Brian Silver, CFO, TScan Therapeutics

Moderator: Brian McVeigh, CEO, Code Biotherapeutics

11:50 pm

CREATING A WORLD WITHOUT DISEASE

Mike Devoy, CMO, Bayer Pharmaceuticals

Bettina Cockroft, CMO, Sangamo

Mike Rosenblatt, Senior Partner, Flagship Pioneering

Ryan Saadi, CEO, Tevogen Bio

Skip Virgin, CSO, Vir Biotechnology

Moderator: Bill Hait, Global Head, External Innovation, Johnson & Johnson

12:25 pm

ACCELERATING DRUG DEVELOPMENT

JC Gutierrez-Ramos, CSO, Danaher

Samit Hirawat, EVP, CMO, Global Drug Development, Bristol Myers Squibb

Rich Moscicki, CMO & EVP, Science & Regulatory Advocacy, PhRMA

Sesha Neervannan, COO, Tarsus

Andrew Pecora, President & Chief Clinical Investigator, Celularity

Moderator: David Weinreich, EVP, Head, Global Clinical Development, Regeneron

4:40 pm

LONGWOOD FUND UPDATE 

Aleks Radovic-Moreno, Partner, Longwood Fund

3:20 pm

FIRESIDE CHAT

David Loew, CEO, Ipsen

Clay Siegall, CEO, Seagen

Moderator: Colin Hill, CEO, GNS Healthcare

1:30 pm

FIRESIDE CHAT

Kabir Nath, CEO, Otsuka US

Ray Sanchez, CMO, Cerevel Therapeutics

Moderator: John Adkisson, President & CEO, Fish & Richardson

7:00 am 

LONGWOOD FUND INTRODUCTION

Christoph Westphal, General Partner, Longwood Fund 

7:30 am

NEWCO TO ESTABLISHED: BUILDING A BIOTECH